FindTrial
Sign In

An ex-vivo study – Basic exploratory research in human ex-vivo tissues which are routinely discarded during orthopedic surgeries

Research proposal for collection of anonymised human tissues for basic exploratory research. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/031567
Enrollment
70
Registered
2021-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Sponsors

Endo Pharmaceuticals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (a) COVID free patients who require surgical remediation for one or more orthopedic surgeries for shoulder or knee joints. (b) Patients who are consenting to donate their tissues (which are routinely discarded during or after shoulder or knee surgeries) for research purpose.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Type & proportion of collagen type present in the harvested tissues before and after treatment with registered pharmaceutical productTimepoint: Tissues will be analyzed within 72 to 96 hours from removal from the body (based on viability of the harvested tissues).—

Secondary

MeasureTime frame
To make better dosage form of the registered marketed product that can possibly provide better treatment options for patients.Timepoint: Tissues will be analyzed within 72 to 96 hours from removal from the body (based on viability of the harvested tissues).—

Countries

India

Contacts

Public ContactBharat B Doshi

BioDev Services Private Limited

bharat.doshi@biodevservices.com9586244544

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026